Haleon is exploring a sale of its ChapStick lip balm business, which could fetch about $600 million, Bloomberg reports, citing people familiar.
Why it matters: Just a few months after spinning out of pharmaceutical giant GSK last year, Haleon is already thinking strategically about ways to bolster its business.
/2023/02/27/1677509521359.gif?w=3840)
